Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PTLA

Portola Pharmaceuticals (PTLA) Stock Price, News & Analysis

Portola Pharmaceuticals logo

About Portola Pharmaceuticals Stock (NASDAQ:PTLA)

Advanced Chart

Key Stats

Today's Range
$18.03
$18.03
50-Day Range
$18.03
$18.03
52-Week Range
$5.31
$31.73
Volume
N/A
Average Volume
3.17 million shs
Market Capitalization
$1.42 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PTLA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Portola Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

PTLA Stock News Headlines

Portola Middle
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Fault lines in Portola Valley
Portola-Butler Continuation High School
Eagle Pharmaceuticals
See More Headlines

PTLA Stock Analysis - Frequently Asked Questions

Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) issued its quarterly earnings data on Monday, May, 11th. The biopharmaceutical company reported ($0.88) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.74) by $0.14. The company's revenue was up 18.9% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Portola Pharmaceuticals investors own include Lexicon Pharmaceuticals (LXRX), Novavax (NVAX), Iovance Biotherapeutics (IOVA), Amarin (AMRN), Editas Medicine (EDIT), Exelixis (EXEL) and Geron (GERN).

Company Calendar

Last Earnings
5/11/2020
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PTLA
CIK
1269021
Fax
N/A
Employees
324
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($4.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$290.66 million
Net Margins
-232.73%
Pretax Margin
N/A
Return on Equity
-267.86%
Return on Assets
-54.66%

Debt

Debt-to-Equity Ratio
4.77
Current Ratio
4.87
Quick Ratio
4.82

Sales & Book Value

Annual Sales
$116.64 million
Price / Sales
12.13
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.67 per share
Price / Book
10.80

Miscellaneous

Outstanding Shares
78,484,000
Free Float
N/A
Market Cap
$1.42 billion
Optionable
Optionable
Beta
2.32
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:PTLA) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners